doi:10.48130/panfungi-0026-0002

[1]

Yuan Y, Wang Y, Sun G, Wang Y, Cao L, et al. 2018. Archaeological evidence suggests earlier use of Ganoderma in Neolithic China. Chinese Science Bulletin 63:1180−1188

doi: 10.1360/n972018-00188

[2]

Sui Q, Zhu C, Shi S, Xu J, Zhang J, et al. 2025. Ganoderic acid A: an in-depth review of pharmacological effects and molecular docking analysis. Journal of Ethnopharmacology 349:119868

doi: 10.1016/j.jep.2025.119868

[3]

Baby S, Johnson AJ, Govindan B. 2015. Secondary metabolites from Ganoderma. Phytochemistry 114:66−101

doi: 10.1016/j.phytochem.2015.03.010

[4]

Galappaththi MCA, Patabendige NM, Premarathne BM, Hapuarachchi KK, Tibpromma S, et al. 2023. A review of Ganoderma triterpenoids and their bioactivities. Biomolecules 13:24

doi: 10.3390/biom13010024

[5]

Fan L, Chen ZJ, Wu CQ, Wang FY. 2019. Quality evaluation of Ganoderma lucidum based on the determination of multi index components by UPLC-MS/MS. Frontiers in Pharmaceutical Sciences 22:844−848

doi: 10.3969/j.issn.1008-049X.2019.05.012

[6]

Du Y, Tian L, Wang Y, Li Z, Xu Z. 2024. Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum. Chinese Medicine 19:51

doi: 10.1186/s13020-024-00922-0

[7]

Zhu T, Liu B, Chen N, Tian X, Li W. 2025. A review of the bioactivities and biosynthesis of Ganoderma lucidum triterpenoids. Mini-Reviews in Organic Chemistry 22:738−755

doi: 10.2174/0118756298331320241203052701

[8]

Raza SHA, Zhong R, Li X, Pant SD, Shen X, et al. 2024. Ganoderma lucidum triterpenoids investigating their role in medicinal applications and genomic protection. Journal of Pharmacy and Pharmacology 76:1535−1551

doi: 10.1093/jpp/rgae133

[9]

Angulo-Sanchez LT, López-Peña D, Torres-Moreno H, Gutiérrez A, Gaitán-Hernández R, et al. 2022. Biosynthesis, gene expression, and pharmacological properties of triterpenoids of Ganoderma Species (Agaricomycetes): a review. International Journal of Medicinal Mushrooms 24:1−17

doi: 10.1615/intjmedmushrooms.2022044016

[10]

Jin M, Cui Y, Li M, Shi Y, Zhou Q, et al. 2025. Research progress on structure, pharmacological action and mechanism of ganoderic acid. Chinese Journal of Modern Applied Pharmacy 42:500−510 (in Chinese)

doi: 10.13748/j.cnki.issn1007-7693.20233268

[11]

Bashir MA, Shao CS, Abdalla M, Yu X, Fetisoa MR, et al. 2026. In silico and in vitro analysis of ganoderic acid a binding to human monocarboxylate transporters 1 and 4. Proteins: Structure, Function, and Bioinformatics 2026:1−16

doi: 10.1002/prot.70126

[12]

Lu J, Zhang T, Jiang C, Hu H, Fei Y, et al. 2025. Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma. International Immunopharmacology 161:114989

doi: 10.1016/j.intimp.2025.114989

[13]

Zhao R, Zhang C, Tang C, Wu X, Hu S, et al. 2025. Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo. Journal of Ethnopharmacology 336:118706

doi: 10.1016/j.jep.2024.118706

[14]

Gill BS, Navgeet, Kumar S. 2016. Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study. Tumor Biology 37:14271−14290

doi: 10.1007/s13277-016-5291-8

[15]

Gill BS, Navgeet, Kumar S. 2019. Antioxidant potential of ganoderic acid in Notch-1 protein in neuroblastoma. Molecular and Cellular Biochemistry 456:1−14

doi: 10.1007/s11010-018-3485-7

[16]

Yang Y, Zhou H, Liu W, Wu J, Yue X, et al. 2018. Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway. Oncology Letters 16:6515−6521

doi: 10.3892/ol.2018.9475

[17]

Shao J, Li Z, Jiao G, Sun G, Zhou Z. 2015. Ganoderic acid A suppresses proliferation and invasion and induces apoptosis in human osteosarcoma cells. Journal of Southern Medical University 35:619−624

doi: 10.3969/j.issn.1673-4254.2015.05.01

[18]

Radwan FFY, Hossain A, God JM, Leaphart N, Elvington M, et al. 2015. Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. Journal of Cellular Biochemistry 116:102−114

doi: 10.1002/jcb.24946

[19]

Shao CS, Feng N, Zhou S, Zheng XX, Wang P, et al. 2021. Ganoderic acid T improves the radiosensitivity of HeLa cells via converting apoptosis to necroptosis. Toxicology Research 10:531−541

doi: 10.1093/toxres/tfab030

[20]

Chen S, Chen K, Lin Y, Wang S, Yu H, et al. 2024. Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels. Toxicology and Applied Pharmacology 491:117069

doi: 10.1016/j.taap.2024.117069

[21]

Liu RM, Zhong JJ. 2011. Ganoderic acid Mf and S induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells. Phytomedicine 18:349−355

doi: 10.1016/j.phymed.2010.08.019

[22]

Luo B, Song L, Chen L, Cai Y, Zhang M, et al. 2024. Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1α destabilization. Phytomedicine 129:155675

doi: 10.1016/j.phymed.2024.155675

[23]

Swallah MS, Bondzie-Quaye P, Yu X, Fetisoa MR, Shao CS, et al. 2025. Elucidating the protective mechanism of ganoderic acid DM on breast cancer based on network pharmacology and in vitro experimental validation. Biotechnology and Applied Biochemistry 72:415−436

doi: 10.1002/bab.2673

[24]

Xia J, Dai L, Wang L, Zhu J. 2020. Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Chemico-Biological Interactions 316:108932

doi: 10.1016/j.cbi.2019.108932

[25]

Ye T, Gao H, Ge Y, Shen R, Yu HY, et al. 2024. Mechanism of ganoderic acid X in treating hepatoblastoma based on proteomics. China Journal of Chinese Materia Medica 49:4158−4166 (in Chinese)

doi: 10.19540/j.cnki.cjcmm.20240412.702

[26]

Xu L, Yan L, Huang S. 2019. Ganoderic acid A against cyclophosphamide-induced hepatic toxicity in mice. Journal of Biochemical and Molecular Toxicology 33:e22271

doi: 10.1002/jbt.22271

[27]

Lv XC, Wu Q, Cao YJ, Lin YC, Guo WL, et al. 2022. Ganoderic acid A from Ganoderma lucidum protects against alcoholic liver injury through ameliorating the lipid metabolism and modulating the intestinal microbial composition. Food & Function 13:5820−5837

doi: 10.1039/D1FO03219D

[28]

Li YQ, Wang SF. 2006. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnology Letters 28:837−841

doi: 10.1007/s10529-006-9007-9

[29]

Cui Y, Qiao FJ, Qiu JH, Liu YF, Gao ZL, et al. 2024. Effect of ganoderic acid A on a mouse model of concanavalin A-induced acute immune liver injury and its mechanism. Journal of Clinical Hepatology 40:2415−2423

doi: 10.12449/JCH241211

[30]

Liu F, Shi K, Dong J, Jin Z, Wu Y, et al. 2020. Ganoderic acid A attenuates high-fat-diet-induced liver injury in rats by regulating the lipid oxidation and liver inflammation. Archives of Pharmacal Research 43:744−754

doi: 10.1007/s12272-020-01256-9

[31]

Ma A, Zhu Y, Ying Y, Wang S, Zhang J, et al. 2026. Ganoderic acids alleviate neuroinflammation by targeting myeloid differentiation factor 2 for ischemic stroke therapy. Exploration 6:20240147

doi: 10.1002/EXP.20240147

[32]

Li QM, Han HH, Zang DD, Zha XQ, Zhou A, et al. 2024. Rapid discovery of Aβ42 fibril disintegrators from Ganoderma lucidum via ligand fishing and their neuroprotective effects on Alzheimer's disease. Journal of Agricultural and Food Chemistry 72:4127−4141

doi: 10.1021/acs.jafc.3c08664

[33]

Sheng F, Zhang L, Wang S, Yang L, Li P. 2020. Deacetyl ganoderic acid f inhibits LPS-induced neural inflammation via NF-κB pathway both in vitro and in vivo. Nutrients 12:85

doi: 10.3390/nu12010085

[34]

Wang D, Cai X, Xu F, Kang H, Li Y, et al. 2022. Ganoderic acid A alleviates the degeneration of intervertebral disc via suppressing the activation of TLR4/NLRP3 signaling pathway. Bioengineered 13:11684−11693

doi: 10.1080/21655979.2022.2070996

[35]

Gill BS, Kumar S, Navgeet. 2017. Ganoderic acid targeting nuclear factor erythroid 2–related factor 2 in lung cancer. Tumor Biology 39:1010428317695530

doi: 10.1177/1010428317695530

[36]

Yuan H, Xu Y, Luo Y, Zhang JR, Zhu XX, et al. 2022. Ganoderic acid D prevents oxidative stress-induced senescence by targeting 14-3-3ε to activate CaM/CaMKII/NRF2 signaling pathway in mesenchymal stem cells. Aging Cell 21:e13686

doi: 10.1111/acel.13686

[37]

Quan YZ, Ma A, Ren CQ, An YP, Qiao PS, et al. 2024. Ganoderic acids alleviate atherosclerosis by inhibiting macrophage M1 polarization via TLR4/MyD88/NF-κB signaling pathway. Atherosclerosis 391:117478

doi: 10.1016/j.atherosclerosis.2024.117478

[38]

Zhang Y, Shi K, Lin T, Xia F, Cai Y, et al. 2020. Ganoderic acid A alleviates myocardial ischemia-reperfusion injury in rats by regulating JAK2/STAT3/NF-κB pathway. International Immunopharmacology 84:106543

doi: 10.1016/j.intimp.2020.106543

[39]

Zheng G, Zhao Y, Li Z, Hua Y, Zhang J, et al. 2023. GLSP and GLSP-derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis. Theranostics 13:1325−1341

doi: 10.7150/thno.80250

[40]

Cheng Y, Zheng G, Huang H, Ni J, Zhao Y, et al. 2025. GLSP mitigates vascular aging by promoting Sirt7-mediated Keap1 deacetylation and Keap1-Nrf2 dissociation. Theranostics 15:4345−4367

doi: 10.7150/thno.110324

[41]

Ma JQ, Zhang YJ, Tian ZK. 2021. Anti-oxidant, anti-inflammatory and anti-fibrosis effects of ganoderic acid A on carbon tetrachloride induced nephrotoxicity by regulating the Trx/TrxR and JAK/ROCK pathway. Chemico-Biological Interactions 344:109529

doi: 10.1016/j.cbi.2021.109529

[42]

Elshamy AM, El Tantawy AF, Basha EH, Eltabaa EF, Arakeeb HM, et al. 2025. Ganoderic acid a potential protective impact on bleomycin (BLM) -induced lung fibrosis in albino mice: targeting caveolin 1/TGF-β/Smad and P38MAPK signaling pathway. Archives of Biochemistry and Biophysics 764:110284

doi: 10.1016/j.abb.2024.110284

[43]

Zhao J, Fan Y, Li H, Wang C, Fan S, et al. 2025. Ganoderic acid A prevented osteoporosis by modulating the PIK3CA/p-Akt/TWIST1 signaling pathway. Food Science & Nutrition 13:e70177

doi: 10.1002/fsn3.70177

[44]

Chen L, Wu B, Mo L, Chen H, Yin X, et al. 2025. High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models. Nature Communications 16:2878

doi: 10.1038/s41467-025-58188-5

[45]

Guzel Erdogan D, Demır A, Baylan H, Budak Ö, Cokluk E, et al. 2025. Effects of different doses of Ganoderic acid A on nociceptive behaviour and inflammatory parameters in polyarthritic mice rheumatoid arthritis model. Scientific Reports 15:15759

doi: 10.1038/s41598-025-99917-6

[46]

Kou RW, Li ZQ, Wang JL, Jiang SQ, Zhang RJ, et al. 2024. Ganoderic acid A mitigates inflammatory bowel disease through modulation of AhR activity by microbial tryptophan metabolism. Journal of Agricultural and Food Chemistry 72:17912−17923

doi: 10.1021/acs.jafc.4c01166

[47]

Zhu JL, Peng FL, Zhang L, Guo YJ, Liu WG, et al. 2026. Ganoderic acid A enhances glycometabolism in mouse gastrocnemius muscle during exercise-induced fatigue via AMPK/PGC-1α Pathway Activation. Food Science & Nutrition 14:e71596

doi: 10.1002/fsn3.71596

[48]

Shang CH. 2009. Molecular cloning, characterization, and differential expression of a lanosterol synthase gene from the fungus Ganoderma lucidum. Master’s Thesis. Nanjing Agricultural University, China. doi: 10.7666/d.Y1762427

[49]

Wang Q, Li Y, Zhang S, Yuan W, Du Z, et al. 2025. Decoding and reprogramming of the biosynthetic networks of mushroom-derived bioactive type II ganoderic acids in yeast. Cell Discovery 11:61

doi: 10.1038/s41421-025-00812-1

[50]

Yang C, Li W, Li C, Zhou Z, Xiao Y, et al. 2018. Metabolism of ganoderic acids by a Ganoderma lucidum cytochrome P450 and the 3-keto sterol reductase ERG27 from yeast. Phytochemistry 155:83−92

doi: 10.1016/j.phytochem.2018.07.009

[51]

Wang WF, Xiao H, Zhong JJ. 2022. Biosynthesis of a novel ganoderic acid by expressing CYP genes from Ganoderma lucidum in Saccharomyces cerevisiae. Applied Microbiology and Biotechnology 106:523−534

doi: 10.1007/s00253-021-11717-w

[52]

Yuan W, Jiang C, Wang Q, Fang Y, Wang J, et al. 2022. Biosynthesis of mushroom-derived type II ganoderic acids by engineered yeast. Nature Communications 13:7740

doi: 10.1038/s41467-022-35500-1

[53]

Fang Y, Luo M, Song X, Shen Y, Xiao H. 2020. Improving the production of squalene-type triterpenoid 2, 3;22, 23-squalene dioxide by optimizing the expression of CYP505D13 in Saccharomyces cerevisiae. Journal of Bioscience and Bioengineering 130:265−271

doi: 10.1016/j.jbiosc.2020.04.005

[54]

Jiang LX, Wang JJ, Li N, Xu JW. 2018. Identification and analysis of cytochrome p450 genes involved in ganoderic acid biosynthesisin Ganoderma lingzhi. Acta Edulis Fungi 25:35−41 (in Chinese)

doi: 10.16488/j.cnki.1005-9873.2018.02.004

[55]

Du Y, Peng S, Chen H, Li J, Huang F, et al. 2025. Unveiling the spatiotemporal landscape of Ganoderma lingzhi: insights into ganoderic acid distribution and biosynthesis. Engineering

doi: 10.1016/j.eng.2025.03.030

[56]

Wang Q, Du Z, Li Z, Yuan W, Zhong JJ, et al. 2025. A branchpoint cytochrome p450 CYP512A13 interconverts different types of ganoderma triterpenoids. ACS Catalysis 15:13428−13443

doi: 10.1021/acscatal.5c04095

[57]

Liu YN, Wu FY, Tian RY, Shi YX, Xu ZQ, et al. 2023. The bHLH-zip transcription factor SREBP regulates triterpenoid and lipid metabolisms in the medicinal fungus Ganoderma lingzhi. Communications Biology 6:1

doi: 10.1038/s42003-022-04154-6

[58]

Wang Y, Xu J, Ruan S, Zhang Y, Xing B, et al. 2023. Cloning, subcellular localization and functional analysis of GlbHLH1 gene in Ganoderma lingzhi. Journal of Agricultural Biotechnology 31:580−593

doi: 10.3969/j.issn.1674-7968.2023.03.013

[59]

Xu J, Wang Y, Zhang Y, Xiong K, Yan X, et al. 2022. Identification of a novel metabolic target for bioactive triterpenoids biosynthesis in Ganoderma lucidum. Frontiers in Microbiology 13:878110

doi: 10.3389/fmicb.2022.878110

[60]

Li J, Zhu X, Du Y, Chen W, Xu J, et al. 2026. Comprehensive genomic identification and functional analysis of bHLH transcription factors in Ganoderma lucidum. Chinese Herbal Medicines 18:200−211

doi: 10.1016/j.chmed.2025.05.005

[61]

Lian LD, Shi LY, Zhu J, Liu R, Shi L, et al. 2022. GlSwi6 positively regulates cellulase and xylanase activities through intracellular Ca²⁺ signaling in Ganoderma lucidum. Journal of Fungi 8:187

doi: 10.3390/jof8020187

[62]

Li H, Zhong JJ. 2020. Role of calcineurin-responsive transcription factor CRZ1 in ganoderic acid biosynthesis by Ganoderma lucidum. Process Biochemistry 95:166−173

doi: 10.1016/j.procbio.2020.05.027

[63]

Wu FL, Zhang G, Ren A, Dang ZH, Shi L, et al. 2016. The pH-responsive transcription factor PacC regulates mycelial growth, fruiting body development, and ganoderic acid biosynthesis in Ganoderma lucidum. Mycologia 108:1104−1113

[64]

Zhu J, Sun Z, Shi D, Song S, Lian L, et al. 2019. Dual functions of AreA, a GATA transcription factor, on influencing ganoderic acid biosynthesis in Ganoderma lucidum. Environmental Microbiology 21:4166−4179

doi: 10.1111/1462-2920.14769

[65]

Meng L, Zhang S, Chen B, Bai X, Li Y, et al. 2021. The MADS-box transcription factor GlMADS1 regulates secondary metabolism in Ganoderma lucidum. Mycologia 113:12−19

doi: 10.1080/00275514.2020.1810515

[66]

Luo Q, Li N, Xu JW. 2022. A methyltransferase LaeA regulates ganoderic acid biosynthesis in Ganoderma lingzhi. Frontiers in Microbiology 13:1025983

doi: 10.3389/fmicb.2022.1025983

[67]

Li HJ, He YL, Zhang DH, Yue TH, Jiang LX, et al. 2016. Enhancement of ganoderic acid production by constitutively expressing Vitreoscilla hemoglobin gene in Ganoderma lucidum. Journal of Biotechnology 227:35−40

doi: 10.1016/j.jbiotec.2016.04.017

[68]

Wang S, Shi L, Hu Y, Liu R, Ren A, et al. 2018. Roles of the Skn7 response regulator in stress resistance, cell wall integrity and GA biosynthesis in Ganoderma lucidum. Fungal Genetics and Biology 114:12−23

doi: 10.1016/j.fgb.2018.03.002

[69]

Xu X, Chen X, Yu W, Liu Y, Zhang W, et al. 2017. Cloning and analysis of the Glwc-1 and Glwc-2 genes encoding putative blue light photoreceptor from Ganoderma lucidum. Journal of Basic Microbiology 57:705−711

doi: 10.1002/jobm.201700016

[70]

Han J, Wang L, Tang X, Liu R, Shi L, et al. 2024. Glsirt1-mediated deacetylation of GlCAT regulates intracellular ROS levels, affecting ganoderic acid biosynthesis in Ganoderma lucidum. Free Radical Biology and Medicine 216:1−11

doi: 10.1016/j.freeradbiomed.2024.02.029

[71]

Ost KJ, Student M, Cord-Landwehr S, Moerschbacher BM, Ram AFJ, et al. 2025. Cell walls of filamentous fungi – challenges and opportunities for biotechnology. Applied Microbiology and Biotechnology 109:125

doi: 10.1007/s00253-025-13512-3

[72]

Huang JY. 2024. Protein kinase A (PKA) regulates ganoderic acid biosynthesis in Ganoderma lucidum. Master’s Thesis. Kunming University of Science and Technology, China. doi: 10.27200/d.cnki.gkmlu.2024.001211 (in Chinese)

[73]

Mu D, Li C, Zhang X, Li X, Shi L, et al. 2014. Functions of the nicotinamide adenine dinucleotide phosphate oxidase family in Ganoderma lucidum: an essential role in ganoderic acid biosynthesis regulation, hyphal branching, fruiting body development, and oxidative-stress resistance. Environmental Microbiology 16:1709−1728

doi: 10.1111/1462-2920.12326

[74]

Li C, Shi L, Chen D, Ren A, Gao T, et al. 2015. Functional analysis of the role of glutathione peroxidase (GPx) in the ROS signaling pathway, hyphal branching and the regulation of ganoderic acid biosynthesis in Ganoderma lucidum. Fungal Genetics and Biology 82:168−180

doi: 10.1016/j.fgb.2015.07.008

[75]

Shi DK, Zhu J, Sun ZH, Zhang G, Liu R, et al. 2017. Alternative oxidase impacts ganoderic acid biosynthesis by regulating intracellular ROS levels in Ganoderma lucidum. Microbiology 163:1466−1476

doi: 10.1099/mic.0.000527

[76]

Wu CG, Tian JL, Liu R, Cao PF, Zhang TJ, et al. 2017. Ornithine decarboxylase-mediated production of putrescine influences ganoderic acid biosynthesis by regulating reactive oxygen species in Ganoderma lucidum. Applied and Environmental Microbiology 83:e01289−e01217

doi: 10.1128/aem.01289-17

[77]

Wang Z, Qiu H, Li Y, Zhao M, Liu R. 2024. GlPRMT5 inhibits GlPP2C1 via symmetric dimethylation and regulates the biosynthesis of secondary metabolites in Ganoderma lucidum. Communications Biology 7:241

doi: 10.1038/s42003-024-05942-y

[78]

Sun B, You H, Xu JW. 2021. Enhancement of ganoderic acid production by promoting sporulation in a liquid static culture of Ganoderma species. Journal of Biotechnology 328:72−77

doi: 10.1016/j.jbiotec.2021.01.014

[79]

Lin J, Yin X, Zeng Y, Hong X, Zhang S, et al. 2023. Progress and prospect: biosynthesis of plant natural products based on plant chassis. Biotechnology Advances 69:108266

doi: 10.1016/j.biotechadv.2023.108266

[80]

Telmer PG, Kelman MJ, Renaud JB, Sumarah MW, Garnham CP. 2022. Application of Aspergillus niger fumonisin amine oxidase (AnFAO) to detoxify fumonisin-contaminated maize. Toxins 14:544

doi: 10.3390/toxins14080544

[81]

Sun Z, Wu Y, Long S, Feng S, Jia X, et al. 2024. Aspergillus oryzae as a cell factory: research and applications in industrial production. Journal of Fungi 10:248

doi: 10.3390/jof10040248

[82]

Ma C, Liu J, Tang J, Sun Y, Jiang X, et al. 2023. Current genetic strategies to investigate gene functions in Trichoderma reesei. Microbial Cell Factories 22:97

doi: 10.1186/s12934-023-02104-3

[83]

Zeng J, Zhou Y, Lyu M, Huang X, Xie M, et al. 2024. Cordyceps militaris: a novel mushroom platform for metabolic engineering. Biotechnology Advances 74:108396

doi: 10.1016/j.biotechadv.2024.108396

[84]

Azi F, Wang Z, Chen W, Lin D, Xu P. 2024. Developing Ganoderma lucidum as a next-generation cell factory for food and nutraceuticals. Trends in Biotechnology 42:197−211

doi: 10.1016/j.tibtech.2023.07.008

[85]

Zhang H, Zhao Q, Xue J, Yu K, Cui S, et al. 2021. Advances in transcriptional regulatory promoters of filamentous fungi and their functions. Journal of Agricultural Sciences 42:56−64

doi: 10.3969/j.issn.1673-0747.2021.04.010

[86]

Leynaud-Kieffer LMC, Curran SC, Kim I, Magnuson JK, Gladden JM, et al. 2019. A new approach to Cas9-based genome editing in Aspergillus niger that is precise, efficient and selectable. PLoS One 14:e0210243

doi: 10.1371/journal.pone.0210243

[87]

Sonderegger C, Galgóczy L, Garrigues S, Fizil Á, Borics A, et al. 2016. A Penicillium chrysogenum-based expression system for the production of small, cysteine-rich antifungal proteins for structural and functional analyses. Microbial Cell Factories 15:192

doi: 10.1186/s12934-016-0586-4

[88]

Wang Y, Liu R, Liu H, Li X, Shen L, et al. 2022. Development of a powerful synthetic hybrid promoter to improve the cellulase system of Trichoderma reesei for efficient saccharification of corncob residues. Microbial Cell Factories 21:5

doi: 10.1186/s12934-021-01727-8

[89]

Deng H, Gao R, Liao X, Cai Y. 2017. Genome editing in Shiraia bambusicola using CRISPR-Cas9 system. Journal of Biotechnology 259:228−234

doi: 10.1016/j.jbiotec.2017.06.1204

[90]

Mózsik L, Pohl C, Meyer V, Bovenberg RAL, Nygård Y, et al. 2021. Modular synthetic biology toolkit for filamentous fungi. ACS Synthetic Biology 10:2850−2861

doi: 10.1021/acssynbio.1c00260

[91]

Polli F, Meijrink B, Bovenberg RAL, Driessen AJM. 2016. New promoters for strain engineering of Penicillium chrysogenum. Fungal Genetics and Biology 89:62−71

doi: 10.1016/j.fgb.2015.12.003

[92]

Chen Y, Liu Y, Shi J, Ma J, Ju J. 2024. CRISPR/Cas systems and their applications in gene editing with filamentous fungi. Synthetic Biology Journal 5:672−693

doi: 10.12211/2096-8280.2023-097

[93]

Twaruschek K, Spörhase P, Michlmayr H, Wiesenberger G, Adam G. 2018. New plasmids for Fusarium transformation allowing positive-negative selection and efficient Cre-loxP mediated marker recycling. Frontiers in Microbiology 9:1954

doi: 10.3389/fmicb.2018.01954

[94]

Zhou CL, Wan JN, Lu XZ, Mao WJ, Tang LH, et al. 2019. Screening and molecular verification of uracil auxotrophic mutants of Ganoderma lucidum. Microbiology China 46:2657−2664 (in Chinese)

doi: 10.13344/j.microbiol.china.180806

[95]

Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806−811

doi: 10.1038/35888

[96]

Romano N, Macino G. 1992. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Molecular Microbiology 6:3343−3353

doi: 10.1111/j.1365-2958.1992.tb02202.x

[97]

Wang S, Chen H, Tang X, Zhang H, Chen W, et al. 2017. Molecular tools for gene manipulation in filamentous fungi. Applied Microbiology and Biotechnology 101:8063−8075

doi: 10.1007/s00253-017-8486-z

[98]

Chen N, Chen M, Wu T, Bian Y, Xu Z. 2020. The development of an efficient RNAi system based on Agrobacterium-mediated transformation approach for studying functional genomics in medical fungus Wolfiporia cocos. World Journal of Microbiology and Biotechnology 36:140

doi: 10.1007/s11274-020-02916-0

[99]

Eom H, Choi YJ, Nandre R, Kim M, Oh YL, et al. 2025. Targeted insertion of heterogenous DNA using Cas9-gRNA ribonucleoprotein-mediated gene editing in Ganoderma lucidum. Bioengineered 16:2458376

doi: 10.1080/21655979.2025.2458376

[100]

Kwon MJ, Schütze T, Spohner S, Haefner S, Meyer V. 2019. Practical guidance for the implementation of the CRISPR genome editing tool in filamentous fungi. Fungal Biology and Biotechnology 6:15

doi: 10.1186/s40694-019-0079-4

[101]

Lin J, Zou G, Liu H, Wei Y. 2023. Application of CRISPR/Cas genome editing technology in the synthesis of secondary metabolites of filamentous fungi. Synthetic Biology Journal 4:738−755

doi: 10.12211/2096-8280.2022-076

[102]

He S, Liu Y, Zhang Z, Cai M, Hao Y, et al. 2025. Gene editing in Ganoderma lucidum: development, challenges, and future prospects. Journal of Fungi 11:310

doi: 10.3390/jof11040310

[103]

Chen T, Chen Z, Zhang H, Li Y, Yao L, et al. 2024. Development of a CRISPR/Cpf1 system for multiplex gene editing in Aspergillus oryzae. Folia Microbiologica 69:373−382

doi: 10.1007/s12223-023-01081-9

[104]

Azi F, Dai XM, Hong YX, Yin LQ, Dong MS, et al. 2025. Sustainable bioproduction of triterpenoid sapogenins and meroterpenoids in a metabolically engineered medicinal mushroom. Green Chemistry 27:318−3123

doi: 10.1039/d4gc06275b

[105]

Abdullah., Wang P, Han T, Liu W, Ren W, et al. 2022. Adenine base editing system for Pseudomonas and prediction workflow for protein dysfunction via ABE. ACS Synthetic Biology 11:1650−1657

doi: 10.1021/acssynbio.2c00066

[106]

Billon P, Bryant EE, Joseph SA, Nambiar TS, Hayward SB, et al. 2017. CRISPR-mediated base editing enables efficient disruption of eukaryotic genes through induction of STOP codons. Molecular Cell 67:1068−1079.e4

doi: 10.1016/j.molcel.2017.08.008

[107]

Xu JW, Xu YN, Zhong JJ. 2012. Enhancement of ganoderic acid accumulation by overexpression of an N-terminally truncated 3-hydroxy-3-methylglutaryl coenzyme a reductase gene in the basidiomycete Ganoderma lucidum. Applied and Environmental Microbiology 78:7968−7976

doi: 10.1128/AEM.01263-12

[108]

Zhang DH, Jiang LX, Li N, Yu X, Zhao P, et al. 2017. Overexpression of the squalene epoxidase gene alone and in combination with the 3-hydroxy-3-methylglutaryl coenzyme a gene increases ganoderic acid production in Ganoderma lingzhi. Journal of Agricultural and Food Chemistry 65:4683−4690

doi: 10.1021/acs.jafc.7b00629

[109]

Fei Y, Li N, Zhang DH, Xu JW. 2019. Increased production of ganoderic acids by overexpression of homologous farnesyl diphosphate synthase and kinetic modeling of ganoderic acid production in Ganoderma lucidum. Microbial Cell Factories 18:115

doi: 10.1186/s12934-019-1164-3

[110]

Zhou JS, Ji SL, Ren MF, He YL, Jing XR, et al. 2014. Enhanced accumulation of individual ganoderic acids in a submerged culture of Ganoderma lucidum by the overexpression of squalene synthase gene. Biochemical Engineering Journal 90:178−183

doi: 10.1016/j.bej.2014.06.008

[111]

Zhang DH, Li N, Yu X, Zhao P, Li T, et al. 2017. Overexpression of the homologous lanosterol synthase gene in ganoderic acid biosynthesis in Ganoderma lingzhi. Phytochemistry 134:46−53

doi: 10.1016/j.phytochem.2016.11.006

[112]

Lan X, Yuan W, Wang M, Xiao H. 2019. Efficient biosynthesis of antitumor ganoderic acid HLDOA using a dual tunable system for optimizing the expression of CYP5150L8 and a Ganoderma P450 reductase. Biotechnology and Bioengineering 116:3301−3311

doi: 10.1002/bit.27154

[113]

Han J, Wang S, Chen X, Liu R, Zhu J, et al. 2022. NAD⁺-dependent Glsirt1 has a key role on secondary metabolism in Ganoderma lucidum. Microbiological Research 258:126992

doi: 10.1016/j.micres.2022.126992

[114]

Liang CX, Li YB, Xu JW, Wang JL, Miao XL, et al. 2010. Enhanced biosynthetic gene expressions and production of ganoderic acids in static liquid culture of Ganoderma lucidum under phenobarbital induction. Applied Microbiology and Biotechnology 86:1367−1374

doi: 10.1007/s00253-009-2415-8

[115]

Meng L, Bai X, Zhang S, Zhang M, Zhou S, et al. 2019. Enhanced ganoderic acids accumulation and transcriptional responses of biosynthetic genes in Ganoderma lucidum fruiting bodies by elicitation supplementation. International Journal of Molecular Sciences 20:2830

doi: 10.3390/ijms20112830

[116]

Xu YN, Zhong JJ. 2012. Impacts of calcium signal transduction on the fermentation production of antitumor ganoderic acids by medicinal mushroom Ganoderma lucidum. Biotechnology Advances 30:1301−1308

doi: 10.1016/j.biotechadv.2011.10.001

[117]

Shi L, Gong L, Zhang X, Ren A, Gao T, et al. 2015. The regulation of methyl jasmonate on hyphal branching and GA biosynthesis in Ganoderma lucidum partly via ROS generated by NADPH oxidase. Fungal Genetics and Biology 81:201−211

doi: 10.1016/j.fgb.2014.12.002

[118]

Cao PF, Wu CG, Dang ZH, Shi L, Jiang AL, et al. 2017. Effects of exogenous salicylic acid on ganoderic acid biosynthesis and the expression of key genes in the ganoderic acid biosynthesis pathway in the lingzhi or reishi medicinal mushroom, Ganoderma lucidum (agaricomycetes). International Journal of Medicinal Mushrooms 19:65−73

doi: 10.1615/IntJMedMushrooms.v19.i1.70

[119]

You BJ, Lee MH, Tien N, Lee MS, Hsieh HC, et al. 2013. A novel approach to enhancing ganoderic acid production by Ganoderma lucidum using apoptosis induction. PLoS One 8:e53616

doi: 10.1371/journal.pone.0053616

[120]

Xu JW, Yue TH, Yu X, Zhao P, Li T, et al. 2019. Enhanced production of individual ganoderic acids by integrating Vitreoscilla haemoglobin expression and calcium ion induction in liquid static cultures of Ganoderma lingzhi. Microbial Biotechnology 12:1180−1187

doi: 10.1111/1751-7915.13381

[121]

Huang XM. 2023. Overexpression of the blue light recptor wc-2 gene increases production of ganodericacids in Ganoderma lucidum. Master’s Thesis. Kunming University of Science and Technology, China

[122]

Ren A, Li XB, Miao ZG, Shi L, Jaing AL, et al. 2014. Transcript and metabolite alterations increase ganoderic acid content in Ganoderma lucidum using acetic acid as an inducer. Biotechnology Letters 36:2529−2536

doi: 10.1007/s10529-014-1636-9

[123]

Zhu LW, Zhong JJ, Tang YJ. 2010. Multi-fed batch culture integrated with three-stage light irradiation and multiple additions of copper ions for the hyperproduction of ganoderic acid and Ganoderma polysaccharides by the medicinal mushroom Ganoderma lucidum. Process Biochemistry 45:1904−1911

doi: 10.1016/j.procbio.2010.03.010

[124]

Lin Z. 2019. Ganoderma (Lingzhi) in traditional Chinese medicine and Chinese culture. In Ganoderma and Health, eds. Lin Z, Yang B. Singapore: Springer. pp. 1−13 doi: 10.1007/978-981-13-9867-4_1

[125]

Jiang S, Li H, Zhang L, Mu W, Zhang Y, et al. 2025. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Research 53:D1670−D1676

doi: 10.1093/nar/gkae973

[126]

Chen S, Liu S, Gao Y, Song Z, Ma H. 2023. Biological characteristics and domestic cultivation of wild Ganoderma gibbosum. Mycosystema 42:2218−2230

doi: 10.13346/j.mycosystema.230059

[127]

Zhu H, Li M, Chu T, Wei M, Zheng H, et al. 2009. Identification of a new Ganoderma lucidum strain, 'Xianzhi 1'. Acta Edulis Fungi 16:25−28

doi: 10.3969/j.issn.1005-9873.2009.03.006

[128]

Tang MX, Chen H, Luo XG, He XL, Yang YR, et al. 2018. Research on a new breeding of Ganoderma lucidum in KangDing. Edible Fungi of China 37:84−86 (in Chinese)

doi: 10.13629/j.cnki.53-1054.2018.05.019

[129]

He L, Yao K, Zhou Z, Jiang N, Luo X. 2022. Breeding research on new Ganoderma lucidum variety 'Yao Chizhi 1'. Science and technology of Sichuan agriculture 2022:15−20

doi: 10.3969/j.issn.1004-1028.2022.05.006

[130]

Xu J, Wang Y, Huang Q, Li Z, Li M, et al. 2021. Breeding of a new Ganoderma lucidum variety 'Xianzhi 3'. Acta Edulis Fungi 28:39−46 (in Chinese)

doi: 10.16488/j.cnki.1005-9873.2021.03.005

[131]

Li Q, Zhou W, Chen Y, Song B, Zou J. 2016. Research progress on Ganoderma lucidum protoplast technology. Edible Fungi 38:1−3

doi: 10.3969/j.issn.1000-8357.2016.05.001

[132]

Li G, Yang F, Li RX, Xu ZX, Li BJ. 2001. A study on the breeding of Ganoderma varieties by UV induced mutagenesisi. Acta Microbiologica Sinica 41:229−233 (in Chinese)

doi: 10.13343/j.cnki.wsxb.2001.02.018

[133]

Dong YW, Miao JZ, Cao ZH, Gao MX, Lu ZQ. 2009. UV mutagenization of protoplast for screening and breeding of high-yield organogemanium-producing strains of Ganoderma lucidum. Food Science 30:188−192

doi: 10.3321/j.issn:1002-6630.2009.15.043

[134]

Tang C, Tan Y, Zhang J, Zhou S, Honda Y, et al. 2023. A novel strain breeding of Ganoderma lucidum UV119 (Agaricomycetes) with high spores yield and strong resistant ability to other microbes' invasions. Foods 12:465

doi: 10.3390/foods12030465

[135]

Dong YW, Miao JZ, Lu ZQ, Cao ZH, Gao MX. 2011. Screening and breeding of high-yield triterpenes-producing Ganoderma lucidum mutants induced by lithium chloride. Food Science 32:120−123

[136]

Zhang L, Wang Y, Zhu H, Li J, Qian H, et al. 2014. Selection of a new Ganoderma lucidum breeding strain, 'XZ-2'. Acta Edulis Fungi 21:15−20

doi: 10.3969/j.issn.1005-9873.2014.01.003

[137]

Nie B, Chen J, Wang W, Cao T, Ye X, et al. 2025. Structural and functional benefits of Ganoderma lucidum polysaccharides due to space mutagenesis. Carbohydrate Polymers 358:123532

doi: 10.1016/j.carbpol.2025.123532

[138]

Song J, Cui LL, Zhou CY, Yao LN, Zhang H. 2024. Research progress of Ganoderma lucidum protoplasmic seed technology. Special Wild Economic Animal and Plant Research 2024:1−4 (in Chinese)

doi: 10.16720/j.cnki.tcyj.2024.136

[139]

Xu J. 2013. Genome research and platform construction of model medicinal mushroom Ganoderma lucidum. PhD. Thesis. Peking Union Medical College, China. doi: 10.7666/d.Y2340634

[140]

Liu XR, Ke BR, Wu XP, Xie BG. 2014. A new Ganoderma lucidum cultivar 'Zhi 102'. Acta Horticulturae Sinica 41:1951−1952 (in Chinese)

doi: 10.16420/j.issn.0513-353x.2014.09.010

[141]

Xiong H, Zhou SS, Peng ZY, Wang XT, Xu J, et al. 2025. Breeding of new Ganoderma lingzhi variety 'Xianzhi 5'. Mycosystema 44:205−216 (in Chinese)

doi: 10.13346/j.mycosystema.250026

[142]

Xie J, Yu Y, You J, Ye Z, Zhou F, et al. 2023. Ganoderma fusions with high yield of ergothioneine and comparative analysis of its genomics. Journal of Fungi 9:1072

doi: 10.3390/jof9111072

[143]

Zhou DX, Kong XM, Huang XM, Li N, Feng N, et al. 2024. Breeding a new Ganoderma lucidum strain with increased contents of individual ganoderic acids by mono – mono crossing of genetically modified monokaryons. Frontiers in Microbiology 15:1410368

doi: 10.3389/fmicb.2024.1410368